Johnson, Nina A <br/><br/>
Assessment of the approved Risk Evaluation and Mitigation Strategy programs for New Drug Applications and Biologics Licensing Applications.  [electronic resource] 

 -  Regulatory toxicology and pharmacology : RTP  Feb 2019 
 - 53-56 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1096-0295 
<br/><br/><label>Standard No.: </label>10.1016/j.yrtph.2018.10.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biological Products<br/>Drug Approval<br/>Risk Evaluation and Mitigation<br/>United States<br/>United States Food and Drug Administration